Biomia Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 6

Biomia General Information

Description

Developer of novel small molecule therapeutics intended to treat CNS (central nervous system) disorders. The company has developed a drug discovery engine founded on machine learning, biosynthesis, and pre-clinical testing of nature-inspired molecule therapeutics to discover and develop novel, safe, and efficacious drug candidates, enabling clients to tackle the unmet needs of patients suffering from neuropsychiatric and neurodegenerative disorders.

Contact Information

Website
www.biomia.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Lersø Parkallé 44
  • 3. tv.
  • 2100 Copenhagen
  • Denmark
+45 61
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Artificial Intelligence & Machine Learning, HealthTech, Life Sciences
Corporate Office
  • Lersø Parkallé 44
  • 3. tv.
  • 2100 Copenhagen
  • Denmark
+45 61

Biomia Timeline

2023202420252026
Date FoundedFinancing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Biomia Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Accelerator/Incubator 09-Feb-2026 Completed Pre-Clinical Trials
4. Early Stage VC Cancelled Pre-Clinical Trials
3. Early Stage VC 01-Oct-2023 Completed Pre-Clinical Trials
2. Accelerator/Incubator Completed Startup
1. University Spin-Out 27-Oct-2022 Completed Startup
To view Biomia’s complete valuation and funding history, request access »

Biomia Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Ordinary
Ordinary
To view Biomia’s complete cap table history, request access »

Biomia Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Biomia Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
One Mind Accelerator/Incubator
Amino Collective Venture Capital Minority
BlueYard Capital Venture Capital Minority
Nucleus Capital Venture Capital Minority
Technical University of Denmark University Minority
You’re viewing 5 of 6 investors. Get the full list »

Ready to get started?

Request a free trial

Biomia FAQs

  • When was Biomia founded?

    Biomia was founded in 2022.

  • Where is Biomia headquartered?

    Biomia is headquartered in Copenhagen, Denmark.

  • What is the size of Biomia?

    Biomia has 10 total employees.

  • What industry is Biomia in?

    Biomia’s primary industry is Drug Discovery.

  • Is Biomia a private or public company?

    Biomia is a Private company.

  • What is Biomia’s current revenue?

    The current revenue for Biomia is .

  • How much funding has Biomia raised over time?

    Biomia has raised $3.04M.

  • Who are Biomia’s investors?

    One Mind, Amino Collective, BlueYard Capital, Nucleus Capital, and Technical University of Denmark are 5 of 6 investors who have invested in Biomia.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process